Search

everythinglearnresearchcommunity

for

Search:↓

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

The treatment is safe and shows promise for metastatic breast cancer.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Enteric hyperoxaluria can cause severe kidney failure after bowel surgery.

The patient showed tumor stability and improved health using a new Periwinkle preparation with chemotherapy.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

The treatment was effective and tolerable for advanced gastric cancer.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

Researchers made new compounds that could potentially be developed into anticancer drugs.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

PXX is an effective and affordable photocatalyst for creating new chemical bonds in organic synthesis.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Estradiol may protect ear cells from hearing loss caused by a chemotherapy drug by activating a protective pathway.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Povidone-iodine nail solution effectively treats nail infections caused by chemotherapy.

The drug showed promise in treating renal cell carcinoma with manageable side effects.